Integra LifeSciences Holdings Corporation (IART)

NASDAQ: IART · Real-Time Price · USD

9.24

+0.07 (0.76%)

At close: Mar 13, 2026, 4:00 PM EDT

9.30

+0.06 (0.65%)

After-hours: Mar 13, 2026, 7:30 PM EDT

IART Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,635	1,611	1,542	1,558	1,542
Revenue Growth (YoY)	1.54%	4.47%	-1.03%	0.99%	12.43%
Cost of Revenue	803.63	728.47	656.84	587.36	597.81
Gross Profit	831.62	882.06	884.74	970.31	944.64
Selling, General & Admin	699.7	716.98	656.64	616.32	637.45
Depreciation & Amortization Expenses	14.95	21.29	12.38	13.88	16.91
Research & Development	98.97	115.38	104.19	101.19	93.05
Other Operating Expenses	511.37	-	-	-	-
Total Operating Expenses	1,325	853.65	773.21	731.39	747.41
Operating Income	-493.37	28.41	111.53	238.92	197.23
Interest Income	18.47	20.04	17.2	11.92	6.74
Interest Expense	-86.26	-70.63	-51.38	-49.59	-50.4
Other Non-Operating Income (Expense)	-2.35	3.94	3.72	12.65	61.11
Total Non-Operating Income (Expense)	-70.13	-46.65	-30.46	-25.03	17.45
Pretax Income	-563.5	-18.24	81.07	213.89	214.68
Provision for Income Taxes	-47.03	-11.29	13.33	33.34	45.6
Net Income	-516.47	-6.94	67.74	180.55	169.08
Net Income to Common	-516.47	-6.94	67.74	180.55	169.08
Net Income Growth	-	-	-62.48%	6.79%	26.28%
Shares Outstanding (Basic)	77	77	80	83	85
Shares Outstanding (Diluted)	77	77	80	84	85
Shares Change (YoY)	-0.44%	-4.14%	-3.81%	-2.30%	0.30%
EPS (Basic)	-6.74	-0.09	0.85	2.18	2.00
EPS (Diluted)	-6.74	-0.09	0.84	2.16	1.98
EPS Growth	-	-	-61.11%	9.09%	26.11%
Free Cash Flow	-31.05	24.96	73.09	222.13	264.41
Free Cash Flow Growth	-	-65.84%	-67.09%	-15.99%	60.30%
Free Cash Flow Per Share	-0.40	0.32	0.91	2.66	3.09
Gross Margin	50.86%	54.77%	57.39%	62.29%	61.24%
Operating Margin	-30.17%	1.76%	7.23%	15.34%	12.79%
Profit Margin	-31.58%	-0.43%	4.39%	11.59%	10.96%
FCF Margin	-1.90%	1.55%	4.74%	14.26%	17.14%
EBITDA	-341.54	169.3	235.04	357.22	317.07
EBITDA Margin	-20.89%	10.51%	15.25%	22.93%	20.56%
EBIT	-493.37	28.41	111.53	238.92	197.23
EBIT Margin	-30.17%	1.76%	7.23%	15.34%	12.79%
Effective Tax Rate	8.35%	61.92%	16.44%	15.59%	21.24%

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q